NCT00748813View on ClinicalTrials.gov

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

Influenza Vaccine, Formulation 2008-2009

1 dose of Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2008-2009

Trial Locations (3)

30034

Site 3, Pianiga

66034

Site 2, Lanciano

66100

Site 1, Chieti

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY